OUR CASE STUDIES

Aurobindo

Aurobindo

CDR acted for Aurobindo Pharma, a generics drugs manufacturer that is listed and headquartered in India, over allegations that its manufacturing processes contributed to the rise in antimicrobial resistance (AMR)

Read more
Royal Mail IPO

Royal Mail IPO

We were appointed HM Government’s sole communications adviser for its transformation, privatisation, IPO and listing of Royal Mail PLC on the London Stock Exchange, 2011 - 2013.

Read more
Hautai Securities

Hautai Securities

CDR acted for Huatai Securities, one of the leading brokerages and wealth management firms in China in its GDR Offering on the London Stock Exchange in June 2019.

Read more